Biolimus A9 DEB for the Treatment of In-Stent Restenosis. 1-year outcomes of the REFORM trial.

1 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Improving techniques and devices for better outcomes in percutaneous coronary interventions Devices ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology